U.S. Erectile Dysfunction Drugs Market Size & Outlook

Name: U.S. Erectile Dysfunction Drugs Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The erectile dysfunction drugs market in the United States is expected to reach a projected revenue of US$ 2,821.1 million by 2033. A compound annual growth rate of 8.7% is expected of the United States erectile dysfunction drugs market from 2026 to 2033.

U.S. erectile dysfunction drugs product outlook (Revenue, USD million, 2021-2033)
- Viagra (sildenafil citrate)
- Cialis (Tadalafil)
- Levitra/Staxyn (vardenafil)
- Stendra/Spedra (avanafil)
- Zydena (udenafil)
- Other Drugs
U.S. erectile dysfunction drugs mode of administration outlook (Revenue, USD million, 2021-2033)
- Oral Mode of Administration
- Injectable Mode of Administration
- Other Modes of Administration

U.S. Erectile Dysfunction Drugs Market Size & Outlook

Sign up - it's easy, and free!